This finding is important for ongoing clinical trials using SC-islet cells, as any retention of immature responsiveness to non-glucose fuels could cause dysregulated insulin secretion and hypoglycaemia [11, 12, 28–30]. This evidence concerns the gene INS and Hypoglycemia.